294 related articles for article (PubMed ID: 11241131)
1. Heparin modulates integrin function in human platelets.
Sobel M; Fish WR; Toma N; Luo S; Bird K; Mori K; Kusumoto S; Blystone SD; Suda Y
J Vasc Surg; 2001 Mar; 33(3):587-94. PubMed ID: 11241131
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
[TBL] [Abstract][Full Text] [Related]
3. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
[TBL] [Abstract][Full Text] [Related]
4. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3.
Francischetti IM; Ghazaleh FA; Reis RA; Carlini CR; Guimarães JA
Arch Biochem Biophys; 1998 May; 353(2):239-50. PubMed ID: 9606958
[TBL] [Abstract][Full Text] [Related]
5. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
6. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
7. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex.
Calvete JJ
Thromb Haemost; 1994 Jul; 72(1):1-15. PubMed ID: 7974356
[TBL] [Abstract][Full Text] [Related]
8. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding.
Manaster Y; Shenkman B; Rosenberg N; Savion N
Thromb Res; 2009 Sep; 124(4):477-82. PubMed ID: 19632706
[TBL] [Abstract][Full Text] [Related]
9. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
10. Factor H binds to platelet integrin alphaIIbbeta3.
Mnjoyan Z; Li J; Afshar-Kharghan V
Platelets; 2008 Nov; 19(7):512-9. PubMed ID: 18979363
[TBL] [Abstract][Full Text] [Related]
11. Exposure of human platelets to plasmin results in the expression of irreversibly active fibrinogen receptors.
Rabhi-Sabile S; Pidard D
Thromb Haemost; 1995 Apr; 73(4):693-701. PubMed ID: 7495081
[TBL] [Abstract][Full Text] [Related]
12. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
Kondo N; Wakayama F; Suzuki Y; Fukui K; Takaya S; Fukuda I
Thromb Res; 2004; 113(5):303-10. PubMed ID: 15183042
[TBL] [Abstract][Full Text] [Related]
13. Tec is involved in G protein-coupled receptor- and integrin-mediated signalings in human blood platelets.
Hamazaki Y; Kojima H; Mano H; Nagata Y; Todokoro K; Abe T; Nagasawa T
Oncogene; 1998 May; 16(21):2773-9. PubMed ID: 9652744
[TBL] [Abstract][Full Text] [Related]
14. Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3).
Biris N; Abatzis M; Mitsios JV; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tselepis AD; Michalis L; Sideris D; Konidou G; Soteriadou K; Tsikaris V
Eur J Biochem; 2003 Sep; 270(18):3760-7. PubMed ID: 12950259
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of signaling from receptors of soluble platelet agonists and outside-in signaling in formation of a stable fibrinogen-integrin αIIbβ3-actin cytoskeleton complex.
Budnik I; Shenkman B; Savion N
Thromb Res; 2015 Jan; 135(1):114-20. PubMed ID: 25456731
[TBL] [Abstract][Full Text] [Related]
16. Platelet integrin alpha IIb beta 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets.
Pedreño J; Fernández R; Cullaré C; Barceló A; Elorza MA; de Castellarnau C
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):156-63. PubMed ID: 9012651
[TBL] [Abstract][Full Text] [Related]
17. Extracellular fibrinogen binding protein, Efb, from Staphylococcus aureus binds to platelets and inhibits platelet aggregation.
Shannon O; Flock JI
Thromb Haemost; 2004 Apr; 91(4):779-89. PubMed ID: 15045140
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation or GPIb.
Jarvis GE; Atkinson BT; Frampton J; Watson SP
Br J Pharmacol; 2003 Feb; 138(4):574-83. PubMed ID: 12598411
[TBL] [Abstract][Full Text] [Related]
19. Polyamines inhibit both platelet aggregation and glycoprotein IIb/IIIa activation.
Corona-de-la-Peña N; Uribe-Carvajal S; Barrientos-Rios R; Matias-Aguilar L; Montiel-Manzano G; Majluf-Cruz A
J Cardiovasc Pharmacol; 2005 Aug; 46(2):216-21. PubMed ID: 16044034
[TBL] [Abstract][Full Text] [Related]
20. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange.
Lahav J; Jurk K; Hess O; Barnes MJ; Farndale RW; Luboshitz J; Kehrel BE
Blood; 2002 Oct; 100(7):2472-8. PubMed ID: 12239158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
